CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Oncternal Therapeutics

For profitWebsite ↗

Also known as: Oncternal Therapeutics | Oncternal Therapeutics, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 20, 2023

Timeline

2010s

Jun 1, 2013
Oncternal Therapeutics— Founded
Jun 1, 2019
GTx— Acquired

Drugs by trial phase (11 distinct, 27 trials)

Phase 3 (2 own, 2 via acquisition)

Phase 2 (3 own, 3 via acquisition)

Phase 1 (1 own, 0 via acquisition)

tk216

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

GTx

Recent trials (7)

NCT05917470OfficialPhase 1/Phase 2Sep 20, 2023
NCT05917470Lead sponsorPhase 1/Phase 2Sep 20, 2023
NCT05588440Lead sponsorPhase 1/Phase 2Dec 31, 2022
NCT05431179Lead sponsorPhase 3Sep 30, 2022
NCT04501939CollaboratorPhase 2Aug 6, 2020
NCT02657005Study directorPhase 1May 1, 2016
NCT02657005Lead sponsorPhase 1May 1, 2016

Details

Founded: Encinitas, CA, US Jun 1, 2013
Last known activity: Sep 20, 2023